What must the labeling of sterile parenteral products include?

The labeling of sterile parenteral products is critical for ensuring patient safety and proper administration. The correct choice emphasizes the importance of including comprehensive information that is necessary for the safe administration of these products.

The rate of infusion is vital because it determines how quickly the medicated solution is delivered to the patient, which can significantly affect the drug's efficacy and the patient's safety. The Beyond Use Date (BUD) is crucial as it indicates how long the product is considered sterile and safe to use post-preparation. Storage requirements must also be clearly labeled to ensure that the product is maintained at appropriate conditions to prevent degradation or contamination.

This detailed labeling is essential in a healthcare setting to prevent errors and ensure that healthcare providers have all the necessary information to administer the product safely and effectively. While patient identification and verifying pharmacist details are important for accountability and traceability, they do not provide the operational guidance that the correct choice does, which focuses on the administration and integrity of the medication itself.